cessive forms of familial FSGS have been described [1] [2] [3] [4] [5] [6] [7] [8] .
Methods. Families were compared for clinical and genetic
The autosomal dominant form of FSGS is generally less heterogeneity. To test for linkage of our family to this portion severe, and patients present at a later age than with the of chromosome 19, genomic DNA was isolated from 102 family autosomal recessive form. FSGS has also been associated members, and polymerase chain reaction was performed using eight microsatellite markers that spanned the area of interest with other congenital syndromes, including Laurenceon chromosome 19. Data were evaluated using two-point link- ily members who were diagnosed as "affected," a misclasalso been mapped to chromosome 19 [16] . Recently, sification parameter of 0.005 was used. Those diagnosed variants in a gene identified and named nephrin, which as "probably affected" were assigned genotype peneencodes a glomerular protein, have been shown to be the trance values of 0.80 for the AA/Aa genotypes and 0.20 defect in Finnish nephropathy, and this gene is located for the aa genotype, where A represents the FSGS allele. within the region on chromosome 19 that is spanned Individuals with the diagnosis of "unknown" were given by D19S223 and D19S213 [17] . In this study, we have a risk of 0.05 of carrying the FSGS allele. These frequeninvestigated a large kindred with familial FSGS and cies were assigned based on our previous observations tested for linkage of their renal disease to this area of in this cohort (abstract; Am J Hum Genet 61:A116, 1997). chromosome 19.
Log 10 of the odds of linkage (LOD) scores were calculated using the Vitesse Program Package [21] . Marker METHODS allele frequencies were calculated using 100 unrelated Ascertainment and evaluation white controls (http://www2.mc.duke.edu/depts/medicine/ medgen/). The marker allele/control frequencies did not Clinical material on Duke family 6530 was initially differ substantially from those calculated from the unreidentified by the Department of Nephrology, Christlated spouses in the family (N ϭ 17). Additionally, a church Hospital, Christchurch, New Zealand ( Fig. 1) .
low-penetrance "affecteds-only" analysis was performed Evaluation of this family included a complete family histo assure that results obtained were not due to asymptory and an assay of serum creatinine and urinalysis where tomatic individuals who were nonpenetrant carriers of appropriate. Asymptomatic individuals were examined the FSGS gene. Map distances for the marker loci were for proteinuria with qualitative urinalysis. Of the individobtained from published data (http://www.gdb.org/) [15] . uals who had undergone renal biopsy, renal pathology Finally, to exclude the possibility that differences in slides were available for review in six cases, and the diagnostic criteria between our study and that reported pathology reports were reviewed on the remainder.
by Mathis et al could account for differences in the outcome of the linkage analysis, we analyzed the data sepa-DNA isolation and genotyping rately using the classification system as Mathis et al deGenomic DNA was isolated from peripheral blood scribed [15] . Heterogeneity was evaluated using the through the Center for Human Genetics, Duke Univeradmixture test as implemented in the HOMOG comsity Medical Center, using PureGene. Genotyping was puter program [22] . carried out as described by Pericak-Vance et al, with the microsatellite markers D19S714, D19S213, D19S425, D19S208, D19S191, D19S220, D19S223, and D19S589 [18] .
RESULTS

Touchdown polymerase chain reaction was performed
Family data using a protocol as previously described in Hecker et al [19] , and markers were optimized with differing concenFamily 6530 (Fig. 1) is a 399 member kindred of British trations of dimethyl sulfoxide as needed [20] .
heritage dating back seven generations from the south of New Zealand. Segregation of the disease in the family Diagnostic criteria followed an autosomal dominant pattern of inheritance. For linkage analysis, individuals were considered to Of the 14 renal biopsies that were available, 13 were be "affected" if they had a renal biopsy demonstrating classified as FSGS, and one was classified as nonspecific FSGS without evidence of other systemic diseases that glomerular changes without evidence of other types of have been known to cause FSGS, if they were on dialysis, kidney disease. Fourteen deceased individuals had or if they had undergone renal transplantation. Family ESRD. Fourteen living family members were on dialysis members with 3ϩ to 4ϩ proteinuria by qualitative urinalor had undergone renal transplantation, and three indiysis, in the absence of other systemic diseases likely to viduals were found to have proteinuria greater than 3ϩ by qualitative urinalysis. Blood samples for DNA were lead to proteinuria, were classified as "probably affected." obtained from a total of 102 individuals, including 13 19q13 in this family. Linkage was excluded (LOD Ͻ Ϫ2.00) at a distance of Ϯ 5 to 10 cm for all markers tested. affected, 2 probably affected, 17 unknown individuals (14 of which were below the mean age of presentation for As depicted in Figure 2 , multipoint linkage analysis of the markers D19S213, D19S191, and D19S223 conclu-FSGS) and 17 unaffected married-in spouses. Of the individuals evaluated with renal disease, the mean age at sively excludes a span of approximately 60 cm in this region for both penetrance models. presentation to a physician was 33 (range 16 to 61 years), with the majority being in their third and fourth decade.
When individuals were reclassified based on the diagnostic criteria of Mathis et al, nine individuals moved The mean amount of proteinuria on presentation to a physician was 3.3 g per 24 hours (range 0.3 to 6.5), and from the "probably affected" and "unknown" categories to the "affected" category [15] . Re-analysis of the data the mean serum creatinine was 1.6 mg/dl (range 0.6 to 4.1). In the patients with ESRD, the average time beusing this classification scheme extended the region of exclusion and thus did not change the outcome of the tween initial presentation and the development of ESRD was 10 years (range 4 to 20 years). Medical problems analysis (data not shown). Furthermore, analysis of homogeneity using the full pedigree model combining the such as diabetes that might be an alternative cause of proteinuria were not present among the individuals clastwo-point results from our study and the study of Mathis et al confirmed evidence of locus heterogeneity [15] . All sified as affected. Also, none of these individuals displayed any evidence of other congenital abnormalities.
markers trended in support of heterogeneity. Marker D19S191 showed significant evidence of heterogeneity Linkage analysis under both the Duke and Mathis et al models with LOD scores of 4.12 (Duke criteria) and 4.38 (Mathis et al The results of the two-point LOD scores for full pedigree and affecteds-only models is as shown in Table 1. criteria), respectively, which is equivalent to odds of more than 10,000:1 in favor of heterogeneity. This analysis does not support linkage to chromosome cally present with nephrotic syndrome. Finnish nephropThe pedigree analysis of kidney disease in this family is athy is different from familial FSGS in that it manifests most consistent with an autosomal dominant inheritance at or shortly after birth, is most common in Finland, and pattern. The patients with kidney disease typically preprogresses to death in the first two years of life unless sented initially to a physician in their third decade and kidney transplantation is performed. Our data indicate had high-grade proteinuria with a progressive course that the familial FSGS in Duke family 6530 and Finnish leading to ESRD in a relatively large percentage of afnephropathy involve lesions at distinct genetic loci. fected individuals. In this study, we have demonstrated
We have excluded linkage of Duke 6530 to the 19q13 genetic heterogeneity within familial FSGS. Unlike the region. Our criteria for assigning the diagnosis of FSGS analyses of another family with FSGS and patients with were very stringent, resulting in a conservative data set. Finnish nephropathy, our studies conclusively exclude Despite this, we were able to exclude an approximately linkage of renal disease in our family to chromosome 19q. 60 cm region with a full pedigree and affecteds-only Indeed, inspection of the diagnostic data on our family model. Family members were not included in the analysis suggests that the genetic heterogeneity observed may repif they had another possible etiology for their renal disresent an underlying clinical heterogeneity between the ease. Additionally, analysis of homogeneity revealed statwo data sets as well (Table 2) . Duke 6530 has a larger tistically significant heterogeneity for multiple markers. proportion of individuals with high-grade proteinuria on There are many familial renal disorders that lead to presentation, a more progressive course, and more indi-ESRD besides FSGS, including adult polycystic kidney viduals who develop ESRD. The age of presentation disease, Alport's nephropathy, and juvenile familial to a physician was also generally earlier in our family.
nephronophthisis [24] [25] [26] [27] [28] . Genes have been identified in Interestingly, the main similarity between the two data each of these disorders. Because ESRD is a major public sets was the pathology results. This divergence of clinical health problem, affecting greater than 200,000 patients presentation supports the genetic linkage evidence prein the United States [29, 30] , and idiopathic FSGS comsented here for the heterogeneity in FSGS.
prises a significant proportion of these patients, it is esFinnish nephropathy is linked to chromosome 19 as sential to understand the molecular basis in hopes of well, and a gene, which is mutated in this disorder (an developing rational treatments and preventions. autosomal recessive congenital nephrotic syndrome), has
There is much speculation as to the underlying basis recently been cloned on 19q13.1 [16, 17, 23] . This is of of FSGS. It is unclear if FSGS is the result of a primary interest because congenital nephrotic syndrome of the glomerular defect or a circulating factor [14] . The early Finnish type has some similarities in pathology, as well recurrence of idiopathic FSGS after renal transplantaas clinical manifestations to FSGS. In both Finnish netion makes the latter explanation appealing as a possibilphropathy and FSGS, there is evidence of tubular atroity. Others have queried environmental causes [31] . FSGS has been called the "final common pathway" of phy, foot process effacement of glomerular epithelial and cancer) [32] [33] [34] [35] [36] [37] [38] . We speculate that this genetic heterIntraglomerular expression of transforming growth factor-beta 1 (TGF-beta 1) mRNA in patients with glomerulonephritis: Quantiogeneity reflects the complex pathogenesis of FSGS. 53:282-286, 1998 with this disorder and invite them to the International
